The Biomedicum Helsinki is a research and teaching center located in the Meilahti district of Helsinki, Finland.

During the past decade, Biomedicum Helsinki conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Biomedicum Helsinki" #1 collaborator was "Finnish Institute of Occupational Health" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Biomedicum Helsinki" are "Atherosclerosis" (1 trials), "COPD" (1 trials), "Chronic Myeloid Leukemia" (1 trials) and "Gastrointestinal Stromal Tumor" (1 trials). Many other conditions were trialed in "Biomedicum Helsinki" in a lesser frequency.

Most popular intervention types in "Biomedicum Helsinki" are "Drug" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "AQX-1125" (1 trials), "Bosutinib" (1 trials), "Placebo" (1 trials), "dasatinib" (1 trials) and "plant stanol ester" (1 trials). Other intervention names were less common.

The vast majority of trials in "Biomedicum Helsinki" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Biomedicum Helsinki". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Biomedicum Helsinki, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Biomedicum Helsinki, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".